Target intelligence / Profile preview

Immunoglobulin heavy variable 3-67-4 (IGHV3-67-4)

Target
IGHV3-67-4
Molecular classification
Other (Immunoglobulin variable region gene)
01

Overview

Immunoglobulin heavy variable 3-67-4 (IGHV3-67-4) is a member of the IGHV gene family, encoding the variable domain of the heavy chain of antibodies (immunoglobulins). The variable region determines the antigen specificity of an antibody and is generated by the recombination of various IGHV, IGHD, and IGHJ gene segments during B-cell development[1][3]. This process produces a diverse repertoire of antibodies capable of recognizing numerous pathogens and antigens. IGHV3 family genes are among the most common and well-studied in humans[3]. The “67-4” designation refers to its specific genetic locus within the IGHV3 subgroup. IGHV segments are not themselves receptors or direct therapeutic targets; rather, they provide the genetic template for assembling antibodies, which may then act as therapeutic agents or be involved in immune-mediated disease processes. Their sequence may be of interest in immunogenetics, diagnostics (e.g., for assessing B-cell clonality), or antibody engineering, but not as classical drug targets[1][3]. If you need information on a specific antibody using this gene segment, or the role of immunoglobulin heavy chain variable regions in therapeutics, please clarify.

Other names
IGHV(III)-67-43-67.4PIGHVIII674IGHVIII-67-4IGHV-3-67-4
02

Biological functions

Antigen recognitionImmune responseGeneration of antibody diversity (through V(D)J recombination)
03

Disease associations

Other (Potential involvement in autoimmune disorders or lymphoid malignancies if rearrangement leads to pathogenic clones; not a primary disease gene)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-67-4 (IGHV3-67-4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-67-4 (IGHV3-67-4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call